BALAXI HEALTHCARE DOMINICANA
⚠️ High Risk
FEI: 3015155413 • Santo Domingo • DOMINICAN REPUBLIC
FEI Number
3015155413
Location
Santo Domingo
Country
DOMINICAN REPUBLICAddress
Jose De Jesus Ravelo 73, , Santo Domingo, , Dominican Republic
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/14/2025 | 61EDY08LORATADINE (ANTI-ASTHMATIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/27/2023 | 56BCY07AMPICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | Division of Southeast Imports (DSEI) | |
| 3/27/2023 | 60LAY01ACETAMINOPHEN (ANALGESIC) | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is BALAXI HEALTHCARE DOMINICANA's FDA import refusal history?
BALAXI HEALTHCARE DOMINICANA (FEI: 3015155413) has 3 FDA import refusal record(s) in our database, spanning from 3/27/2023 to 5/14/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. BALAXI HEALTHCARE DOMINICANA's FEI number is 3015155413.
What types of violations has BALAXI HEALTHCARE DOMINICANA received?
BALAXI HEALTHCARE DOMINICANA has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about BALAXI HEALTHCARE DOMINICANA come from?
All FDA import refusal data for BALAXI HEALTHCARE DOMINICANA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.